Pharmaceutical Project Management

Author:   Anthony Kennedy ,  James Swarbrick (PharmaceuTech, Inc, Pinehurst, North Carolina, USA) ,  Lukas Von Hippel ,  Anthony Kennedy (Trigen Ltd, London, England, UK)
Publisher:   Taylor & Francis Inc
Edition:   2nd edition
Volume:   182
ISBN:  

9780849340246


Pages:   282
Publication Date:   17 March 2008
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $368.00 Quantity:  
Add to Cart

Share |

Pharmaceutical Project Management


Add your own review!

Overview

Full Product Details

Author:   Anthony Kennedy ,  James Swarbrick (PharmaceuTech, Inc, Pinehurst, North Carolina, USA) ,  Lukas Von Hippel ,  Anthony Kennedy (Trigen Ltd, London, England, UK)
Publisher:   Taylor & Francis Inc
Imprint:   CRC Press Inc
Edition:   2nd edition
Volume:   182
Dimensions:   Width: 15.20cm , Height: 1.90cm , Length: 22.90cm
Weight:   0.476kg
ISBN:  

9780849340246


ISBN 10:   0849340241
Pages:   282
Publication Date:   17 March 2008
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Strategic Project Management. Strategic Portfolio Management. Project Management, Planning and Tracking-From Basic Concepts to Application. Discovery Project Management. Preclinical Project Management. Project Management of Chemistry, Manufacturing and Control. Clinical Project Management. Project Management of Registration and Product Launch. Life Cycle Project Management. Project Managing People and Teams. Project Management of Contracted Development. Training in Project Management

Reviews

This book is easy to read, contains a wealth of information of the 'how-to' variety and highlights many of the stumbling-blocks to efficient project management. It will help 'novices' prepare to manage their project meeting, and allow a 'Well, at least I'm not the only one with that problem,' companionship for the experienced project manager. ---European Journal of Parenteral Sciences (for previous edition) . . .A major aspect of the book is of value for those either new to the pharmaceutical industry or newly assuming broader project responsibilities is the comprehensive discussion of the drug development process. ---Journal of Controlled Release (for previous edition)


This book is easy to read, contains a wealth of information of the 'how-to' variety and highlights many of the stumbling-blocks to efficient project management. It will help 'novices' prepare to manage their project meeting, and allow a 'Well, at least I'm not the only one with that problem, ' companionship for the experienced project manager. ---European Journal of Parenteral Sciences (for previous edition) . . .A major aspect of the book is of value for those either new to the pharmaceutical industry or newly assuming broader project responsibilities is the comprehensive discussion of the drug development process. ---Journal of Controlled Release (for previous edition)


Author Information

Tony Kenedy is Vice President of Development at Trigen, Ltd in London, U.K. Dr. Kennedy, a Medical Research Council Postdoctoral Research Fellow at The School of Pharmacy, London University, U.K., was awarded his Ph.D. by London University, U.K. and was previously the Global Head of Project Management at Roche, Switzerland. He was the editor of the first edition of Pharmaceutical Project Management which was published by Marcel Dekker in 1998, and his career has been devoted to the discovery and development of novel drugs while working in large pharmaceutical and small biotech companies. Dr. Kennedy has directed global drug development teams in several therapeutic areas including cardiovascular, gastrointestinal, infectious disease, rheumatology and oncology, and led the Roche-Gilead joint development team that took the flu antiviral Tamiflu to registration three years after the discovery of the molecule.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List